sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Europe Pharmacogenomics Market 2020-2030 by Service (Genotyping, SNP, Diagnostics), Technology (PCR, Microarray, Sequencing, Electrophoresis, MS), Application, End User, and Country: Trend Forecast and Growth Opportunity

Europe Pharmacogenomics Market 2020-2030 by Service (Genotyping, SNP, Diagnostics), Technology...

Home / Categories / Healthcare
Europe Pharmacogenomics Market 2020-2030 by Service (Genotyping, SNP, Diagnostics), Technology (PCR, Microarray, Sequencing, Electrophoresis, MS), Application, End User, and Country: Trend Forecast and Growth Opportunity
Europe Pharmacogenomics Market 2020-2030 by...
Report Code
RO1/105/1048

Publish Date
28/Sep/2020

Pages
125
PRICE
$ 2800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 3800/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 4800/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on the Market 25
2.2 Major Growth Drivers 27
2.3 Market Restraints and Challenges 31
2.4 Emerging Opportunities and Market Trends 34
2.5 Porters Fiver Forces Analysis 38
3 Segmentation of Europe Market by Service 42
3.1 Market Overview by Service 42
3.2 Genotyping 44
3.3 SNP Identification 45
3.4 Diagnostics 46
3.5 Other Services 48
4 Segmentation of Europe Market by Technology 49
4.1 Market Overview by Technology 49
4.2 Polymerase Chain Reaction (PCR) 51
4.3 Microarray 52
4.4 Sequencing 53
4.5 Electrophoresis 54
4.6 Mass Spectrometry 55
4.7 Other Technologies 56
5 Segmentation of Europe Market by Application 57
5.1 Market Overview by Application 57
5.2 Oncology 59
5.3 Infectious Diseases 60
5.4 Neurology/Psychiatry 61
5.5 Cardiovascular 63
5.6 Pain Management 64
5.7 Other Applications 65
6 Segmentation of Europe Market by End User 66
6.1 Market Overview by End User 66
6.2 Hospitals and Clinics 68
6.3 Pharmaceutical Companies 69
6.4 Research Institutes 70
7 European Market 2019-2030 by Country 71
7.1 Overview of European Market 71
7.2 Germany 74
7.3 UK 76
7.4 France 79
7.5 Spain 81
7.6 Italy 83
7.7 Russia 85
7.8 Rest of European Market 87
8 Competitive Landscape 89
8.1 Overview of Key Vendors 89
8.2 New Product Launch, Partnership, Investment, and M&A 93
8.3 Company Profiles 94
23andMe, Inc. 94
Abbott Laboratories 96
Admera Health, LLC 97
Agena Biosciences, Inc. 98
Astra Zeneca PLC 99
Bayer AG 100
Becton, Dickinson and Company 101
Cancer Genetics, Inc. 102
Dynamic DNA Laboratories 103
Empire Genomics LLC 104
F. Hoffmann-La Roche Ltd 105
geneOmbio Technologies Pvt Ltd. 106
Genomic Health, Inc. 107
Illumina, Inc. 108
Laboratory Corporation of America Holdings 109
Myriad Genetics Inc. 110
Oneome LLC 111
Opko Health, Inc. 112
Pathway Genomics Corporation 113
QIAGEN N.V. 114
Quest Diagnostics Incorporated 115
Teva Pharmaceuticals Industries Ltd. 116
Thermo Fisher Scientific Inc. 117
Transgenomic, Inc. 118
9 Investing in Europe Market: Risk Assessment and Management 119
9.1 Risk Evaluation of Europe Market 119
9.2 Critical Success Factors (CSFs) 122
Related Reports and Products 125

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com